| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.17.10.2250 |
| P698 | PubMed publication ID | 9351397 |
| P2093 | author name string | Palinski W | |
| Merat S | |||
| Reaven P | |||
| Casanada F | |||
| Sutphin M | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| hyperglycemia | Q271993 | ||
| P304 | page(s) | 2250-2256 | |
| P577 | publication date | 1997-10-01 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice | |
| P478 | volume | 17 |
| Q37666671 | 2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis |
| Q44326992 | Aldose reductase mediates the mitogenic signals of cytokines |
| Q34591282 | Animal models of cardiovascular diseases |
| Q35179999 | Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor. |
| Q36933488 | Berberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathy |
| Q45937038 | Cardiovascular risk continuum: implications of insulin resistance and diabetes. |
| Q37011769 | Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations |
| Q37643127 | Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis |
| Q37333371 | Diabetes and atherosclerosis: is there a role for hyperglycemia? |
| Q37486465 | Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions |
| Q36401585 | Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention |
| Q53486855 | Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs. |
| Q36199128 | Diabetic vascular disease and the potential role of macrophage glucose metabolism |
| Q37727913 | Dichotomous mechanisms of aortic stiffening in high-fat diet fed young and old B6D2F1 mice |
| Q37083092 | Does Elevated Glucose Promote Atherosclerosis? Pros and Cons |
| Q45241682 | Effects of diabetes and CETP expression on diet-induced atherosclerosis in LDL receptor-deficient mice. |
| Q50963014 | Expression of the human beta3 integrin subunit in mouse smooth muscle cells enhances IGF-I-stimulated signaling and proliferation. |
| Q34080318 | Genetic modifiers of atherosclerosis in mice |
| Q93026142 | High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus |
| Q24530027 | Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice |
| Q55355643 | Hyperglycemia does not affect tissue repair responses in shear stress-induced atherosclerotic plaques in ApoE-/- mice. |
| Q37711215 | Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis |
| Q34006304 | Immunological responses to oxidized LDL. |
| Q44702438 | Improvement in myocardial function by Terminalia arjuna in streptozotocin-induced diabetic rats: possible mechanisms. |
| Q38344254 | Increased CD36 protein as a response to defective insulin signaling in macrophages |
| Q34513915 | Increased inflammation in atherosclerotic lesions of diabetic Akita-LDLr⁻/⁻ mice compared to nondiabetic LDLr⁻/⁻ mice |
| Q27011696 | Insulin resistance, hyperglycemia, and atherosclerosis |
| Q26766350 | Large animal models of cardiovascular disease |
| Q35827889 | Left ventricular diastolic dysfunction in nonhuman primate model of dysmetabolism and diabetes |
| Q33922264 | Lipoprotein modification and atherosclerosis in aging |
| Q44517931 | Lipoprotein subclass profiles of hyperlipidemic diabetic mice measured by nuclear magnetic resonance spectroscopy |
| Q36942584 | Minimization of the Risk of Diabetic Microangiopathy in Rats by Nigella sativa |
| Q35956425 | Mouse betaine-homocysteine S-methyltransferase deficiency reduces body fat via increasing energy expenditure and impairing lipid synthesis and enhancing glucose oxidation in white adipose tissue |
| Q32052554 | Naturally occurring and experimental diabetes in cynomolgus monkeys: a comparison of carbohydrate and lipid metabolism and islet pathology |
| Q43687605 | Non-obese diabetic (NOD) mice exhibit an increased cellular immune response to glycated-LDL but are resistant to high fat diet induced atherosclerosis |
| Q28362804 | PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice |
| Q37108304 | Progression and disruption of advanced atherosclerotic plaques in murine models |
| Q36416215 | Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models? |
| Q46141600 | Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice |
| Q90330835 | The Effects of Natural Clinoptilolite and Nano-Sized Clinoptilolite Supplementation on Lipid Profile, Food Intakes and Body Weight in Rats with Streptozotocin-Induced Diabetes |
| Q36428268 | Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behavior |
| Q35881759 | Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture |
| Q39951404 | Why does diabetes increase atherosclerosis? I don't know! |
Search more.